Literature DB >> 3990574

Purification of human platelet-derived growth factor.

E W Raines, R Ross.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3990574     DOI: 10.1016/0076-6879(85)09128-5

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  29 in total

1.  The use of autologous blood-derived growth factors in bone regeneration.

Authors:  Roberto Civinini; Armando Macera; Lorenzo Nistri; Birgit Redl; Massimo Innocenti
Journal:  Clin Cases Miner Bone Metab       Date:  2011-01

2.  Derivation and properties of platelet-derived growth factor-independent rat smooth muscle cells.

Authors:  S M Schwartz; L Foy; D F Bowen-Pope; R Ross
Journal:  Am J Pathol       Date:  1990-06       Impact factor: 4.307

3.  Purification and analysis of proteinase-resistant mutants of recombinant platelet-derived growth factor-BB exhibiting improved biological activity.

Authors:  A L Cook; P M Kirwin; S Craig; L J Bawden; D R Green; M J Price; S J Richardson; A Fallon; A H Drummond; R M Edwards
Journal:  Biochem J       Date:  1992-01-01       Impact factor: 3.857

4.  Platelet-derived growth factor activity and mRNA expression in healing vascular grafts in baboons. Association in vivo of platelet-derived growth factor mRNA and protein with cellular proliferation.

Authors:  M A Golden; Y P Au; T R Kirkman; J N Wilcox; E W Raines; R Ross; A W Clowes
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

5.  Rapid and selective alterations in the expression of cellular genes accompany conditional transcription of Ha-v-ras in NIH 3T3 cells.

Authors:  R D Owen; M C Ostrowski
Journal:  Mol Cell Biol       Date:  1987-07       Impact factor: 4.272

6.  Epiregulin is a potent vascular smooth muscle cell-derived mitogen induced by angiotensin II, endothelin-1, and thrombin.

Authors:  D S Taylor; X Cheng; J E Pawlowski; A R Wallace; P Ferrer; C J Molloy
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

7.  Human thrombopoietin: gene structure, cDNA sequence, expression, and chromosomal localization.

Authors:  D C Foster; C A Sprecher; F J Grant; J M Kramer; J L Kuijper; R D Holly; T E Whitmore; M D Heipel; L A Bell; A F Ching
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

8.  PDGF and FGF stimulate wound healing in the genetically diabetic mouse.

Authors:  D G Greenhalgh; K H Sprugel; M J Murray; R Ross
Journal:  Am J Pathol       Date:  1990-06       Impact factor: 4.307

9.  Ranibizumab is a potential prophylaxis for proliferative vitreoretinopathy, a nonangiogenic blinding disease.

Authors:  Steven Pennock; David Kim; Shizuo Mukai; Matthew Kuhnle; Dal W Chun; Joanne Matsubara; Jing Cui; Patrick Ma; David Maberley; Arif Samad; Robert J Van Geest; Sarit L Oberstein; Reinier O Schlingemann; Andrius Kazlauskas
Journal:  Am J Pathol       Date:  2013-04-09       Impact factor: 4.307

10.  Lysophosphatidylcholine upregulates the level of heparin-binding epidermal growth factor-like growth factor mRNA in human monocytes.

Authors:  T Nakano; E W Raines; J A Abraham; M Klagsbrun; R Ross
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.